Dr. Jeffrey Crawford
Claim this profileDuke University Medical Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
21 reported clinical trials
57 drugs studied
About Jeffrey Crawford
Education:
- Obtained an MD from the University of North Carolina School of Medicine in 1978.
- Completed a Residency in Internal Medicine at Duke University Medical Center in 1981.
- Finished a Fellowship in Hematology/Oncology at Duke University Medical Center in 1983.
Experience:
- Currently a Professor of Medicine at Duke University School of Medicine.
- Serves as the Director of the Breast Cancer Program at the Duke Cancer Institute.
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
2Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Jeffrey Crawford is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
DSC-MRI
for Recurrent Glioblastoma
This phase II trial studies how well dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI) works in measuring relative cerebral blood volume (rCBV) for early response to bevacizumab in patients with glioblastoma that has come back. DSC-MRI may help evaluate changes in the blood vessels within the cancer to determine a patient?s response to treatment.
Recruiting1 award N/A
More about Jeffrey Crawford
Clinical Trial Related5 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Jeffrey Crawford has experience with
- Pembrolizumab
- Carboplatin
- Rituximab
- Autologous Hematopoietic Stem Cell Transplantation
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
Breakdown of trials Jeffrey Crawford has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey Crawford specialize in?
Jeffrey Crawford focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Jeffrey Crawford currently recruiting for clinical trials?
Yes, Jeffrey Crawford is currently recruiting for 8 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey Crawford has studied deeply?
Yes, Jeffrey Crawford has studied treatments such as Pembrolizumab, Carboplatin, Rituximab.
What is the best way to schedule an appointment with Jeffrey Crawford?
Apply for one of the trials that Jeffrey Crawford is conducting.
What is the office address of Jeffrey Crawford?
The office of Jeffrey Crawford is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.